new combo drug, Juvisync (JU-vih-sink), for treating diabetes

You'll see a new combo drug, Juvisync (JU-vih-sink), for treating diabetes.

Juvisync combines sitagliptin (Januvia) and simvastatin (Zocor) in one tab. It's the first "gliptin-statin" combo on the market.

Using these drugs together makes sense. Diabetes is a big risk factor for developing heart disease...and so is high cholesterol.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote